© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Pharming Group N.V. (PHAR) shows an Average True Range (ATR) of 0.81 and an Enterprise Value of 790.35M. Its average trading volume over the past 3 months is 23.9K, indicating liquidity. These fundamental metrics provide insight into PHAR's underlying financial health and market activity.
| ATR | 0.81 |
| Enterprise Value | 790.35M |
| Avg Vol (3 Months) | 23.9K |
| Avg Vol (10 Days) | 4.94K |
Pharming Group N.V. (PHAR) technical indicators as of May 2, 2026: the SMA 20 is -2.53%, SMA 50 at -6.45%, and SMA 200 at 15.67%. The RSI 14 value is 44.33, suggesting its current momentum. These technical analysis signals help assess PHAR's price trends and potential future movements.
| SMA 20 | -2.53% |
| SMA 50 | -6.45% |
| SMA 200 | 15.67% |
| RSI 14 | 44.33 |
Pharming Group N.V. (PHAR) stock performance overview as of May 2, 2026: The 52-week high is $21.34 (currently -23.29% below), and the 52-week low is $8.6 (currently 118.21% above). Over the past year, PHAR's performance is 71.32%, compared to the S&P 500's 17.86% change.
| 52-Week High | 21.34 |
| 52-Week High Chg | -23.29% |
| 52-Week Low | 8.6 |
| 52-Week Low Chg | +118.21% |
| S&P 500 52-Week Chg | 17.86% |
According to market data, Pharming Group N.V. (PHAR) stock's recent performance metrics show that over the last month, PHAR is 7.89%, with a Year-to-Date (YTD) performance of 1.41%. Over the past year, the stock has seen a 71.32% change. These figures summarize PHAR's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 17.01 | 18.11 | 21.34 | 21.34 | 21.34 | 21.34 |
| Low | 16.36 | 15.74 | 14.5 | 12.68 | 8.6 | 14.5 |
| Performance | -4.58% | +7.89% | +28.00% | +75.26% | +71.32% | +1.41% |
According to current financial data, PHAR stock's P/E (TTM) ratio is 388.89, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for PHAR, including P/S (3.09), P/B (3.96), and P/FCF (23.88), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | PHAR | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 388.89 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | 3.09 | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 3.96 | 6.53 | 1.01 | 4.72 |
| P/FCF (TTM) | 23.88 | -0.02 | -462.17 | 32.8 |